نتایج جستجو برای: brca mutation

تعداد نتایج: 292614  

2016
Zora Baretta Simone Mocellin Elena Goldin Olufunmilayo I. Olopade Dezheng Huo

BACKGROUND The contribution of BRCA germline mutational status to breast cancer patients' prognosis is unclear. We aimed to systematically review and perform meta-analysis of the available evidence of effects of BRCA germline mutations on multiple survival outcomes of breast cancer patients as a whole and in specific subgroups of interest, including those with triple negative breast cancer, tho...

2011
Alicia A Tone Carl Virtanen Patricia A Shaw Theodore J Brown

We previously reported that BRCA1/2-mutated fallopian tube epithelium (FTE) collected during the luteal phase exhibits gene expression profiles more closely resembling that of high-grade serous carcinoma (HGSC) specimens than FTE collected during the follicular phase or from control patients. Since the luteal phase is characterised by high levels of progesterone, we determined whether the expre...

2016
Anthony Eccleston Anthony Bentley Matthew Dyer Ann Strydom Wim Vereecken Angela George Nazneen Rahman

Objectives: The objective of this study was to evaluate the long-term cost-effectiveness of germline BRCA1 and BRCA2 (collectively termed ‘BRCA’) testing in women with epithelial ovarian cancer, and testing for the relevant mutation in first and second degree relatives of BRCA mutation-positive individuals, compared with no testing. Female BRCA mutation-positive relatives of ovarian cancer pati...

Journal: :JOP : Journal of the pancreas 2012
Richard Kim Jenifer Byer Muhammad Wasif Saif

Germline mutations in BRCA genes are associated with increased risk of pancreatic cancer. There are pre clinical data which suggests that DNA cross linking agents should be used in pancreatic cancer patients with BRCA mutations. This review is an update from the 2012 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium regarding recent developments in the treatment of...

2010
Paige Teller Rita K Kramer

Current management of an asymptomatic BRCA mutation carrier includes early initiation and intensive cancer screening in combination with risk reduction strategies. The primary objectives of these interventions are earlier detection and cancer prevention to increase quality of life and prolonged survival. Existing recommendations are often based on the consensus of experts as there are few, supp...

Journal: :American journal of cancer research 2015
Zeina Nahleh Salman Otoukesh Alok Kumar Dwivedi Indika Mallawaarachchi Luis Sanchez J Salvador Saldivar Kayla Cataneda Rosalinda Heydarian

UNLABELLED Hispanics in El Paso, TX, a large American-Mexican border city constitute 85% of the population. Limited cancer research has been conducted in this population. We sought to study the prevalence of BRCA mutations among Hispanic patients of Mexican origin, identify reported Mexican founder or recurrent mutations, and study the breast cancer characteristics in mutation carriers. METHO...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Lovise Maehle Jaran Apold Torbjørn Paulsen Bjørn Hagen Kjell Løvslett Bent Fiane Marijke Van Ghelue Neal Clark Pål Møller

PURPOSE Inherited ovarian cancer carries a serious prognosis. Prophylactic oophorectomy has been advocated. The degree to which inherited ovarian cancer is restricted to BRCA mutation carriers is not fully known. We wanted to determine the prevalence of BRCA mutation carriers in women at high risk from ovarian cancer. EXPERIMENTAL DESIGN Healthy women who were found to be at increased risk ju...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
David J Gallagher Mia M Gaudet Prodipto Pal Tomas Kirchhoff Lisa Balistreri Kinjal Vora Jasmine Bhatia Zsofia Stadler Samson W Fine Victor Reuter Michael Zelefsky Michael J Morris Howard I Scher Robert J Klein Larry Norton James A Eastham Peter T Scardino Mark E Robson Kenneth Offit

PURPOSE Increased prostate cancer risk has been reported for BRCA mutation carriers, but BRCA-associated clinicopathologic features have not been clearly defined. EXPERIMENTAL DESIGN We determined BRCA mutation prevalence in 832 Ashkenazi Jewish men diagnosed with localized prostate cancer between 1988 and 2007 and 454 Ashkenazi Jewish controls and compared clinical outcome measures among 26 ...

2015
Zsuzsanna Suba

Currently available scientific evidence erroneously suggests that mutagenic weakness or loss of the BRCA1/2 genes may liberate the proliferative effects of estrogen signaling, which provokes DNA damage and genomic instability. Conversely, BRCA mutation seems to be an imbalanced defect, crudely inhibiting the upregulation of estrogen receptor expression and liganded transcriptional activity, whe...

2011
Annemiek Visser Judith B Prins Nicoline Hoogerbrugge Hanneke WM van Laarhoven

BACKGROUND BRCA mutation carriers have a 40-80% life-time risk of developing breast cancer. They may opt for yearly breast cancer surveillance or for prophylactic mastectomy. Both options show increased survival rates. It is a complex choice to be made between these two options. As a result most women experience high levels of distress and high needs for information. To fulfill the needs for ps...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید